VANI
https://investors.vivani.com/investors/news-events/press-releases/detail/167/vivani-medical-announces-positive-npm-115-preclinical
https://investors.vivani.com/investors/news-events/press-releases/detail/168/vivani-medical-announces-pricing-of-15-0-million
https://investors.vivani.com/investors/news-events/press-releases/detail/173/vivani-medical-announces-publication-of-positive-weight
https://investors.vivani.com/investors/news-events/press-releases/detail/172/vivani-medical-provides-business-update-and-reports-first
https://vivani.com/nanoportal/
https://www.cortigent.com/orion
https://www.youtube.com/watch?v=m2WXEjewqho&t=118s
ACHV
https://ir.achievelifesciences.com/news-events/press-releases/detail/204/achieve-life-sciences-announces-fda-grants-breakthrough
ATNM
https://ir.actiniumpharma.com/press-releases/detail/486/actinium-provides-regulatory-update-on-planned-bla-filing
VNDA
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://vandapharmaceuticalsinc.gcs-web.com/node/16086/pdf
ASXM
https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-reports-second-quarter-2024-financial
ALGS
https://investor.aligos.com//news-releases/news-release-details/aligos-therapeutics-reports-recent-business-progress-and-3
GRAL
https://investors.grail.com/news-releases/news-release-details/grail-announce-second-quarter-2024-financial-results
VERU
https://ir.verupharma.com/news-events/press-releases/detail/217/veru-to-report-fiscal-2024-third-quarter-financial-results
CAPR
https://www.capricor.com/investors/news-events/press-releases/detail/286/capricor-therapeutics-to-present-second-quarter-2024
ALT
https://ir.altimmune.com/news-releases/news-release-details/altimmune-report-second-quarter-2024-financial-results-and
DERM
https://ir.journeymedicalcorp.com/new-events/press-releases/detail/69/journey-medical-corporation-to-announce-second-quarter-2024
BRTX
https://www.biorestorative.com/press-releases/

